An update on China's national policies regarding rare diseases-Reference-Cited by-同舟云学术

An update on China's national policies regarding rare diseases

Published:2021-08-31 Issue:3 Volume:10 Page:148-153
ISSN:2186-361X
Container-title:Intractable & Rare Diseases Research
language:en
Short-container-title:IRDR

Author:

Ying Zhiye¹,Gong Li²,Li Chunyang¹

Affiliation:

1. Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

2. Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/irdr/10/3/10_2021.01027/_pdf

Reference21 articles.

1. 1. Haendel M, Vasilevsky N, Unni D, et al. How many rare diseases are there? Nat Rev Drug Discov. 2020; 19:77-78.

2. 2. Guangming Daily. A series of policies benefit 20 million patients with rare diseases. https://news.gmw.cn/2019-03/02/content_32590501.htm (accessed November 30, 2020) (in Chinese).

3. 3. He JJ, Kang Q, Hu JH, Song PP, Jin CL. China has officially released its first national list of rare diseases. Intractable Rare Dis Res. 2018; 7:145-147.

4. 4. Xinhua News Agency. China Rare Disease Alliance established. http://www.xinhuanet.com/politics/2018-10/26/c_1123619519.htm (accessed December 2, 2020) (in Chinese).

5. 5. National Health Commission of the People's Republic of China. Notice of the General Office of the National Health Commission on the establishment of a National Network for Collaboration in Rare Disease Diagnosis and Treatment. http://www.nhc.gov.cn/yzygj/s7659/201902/3a8228589bf94e6d9356008763387cc4.shtml (accessed December 2, 2020) (in Chinese).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the new drug access gap between China and the United States and its related policies;Frontiers in Pharmacology;2024-01-08

2. Release and impact of China's "Second List of Rare Diseases";Intractable & Rare Diseases Research;2023-11-30

3. Pharmacovigilance for rare diseases: a bibliometrics and knowledge-map analysis based on web of science;Orphanet Journal of Rare Diseases;2023-09-26

4. Knowledge and Attitudes of Clinical Trials among Patients with Rare Diseases and the Guardians in China;Therapeutic Innovation & Regulatory Science;2023-09-18

5. Policy analysis in the field of rare diseases in China: a combined study of content analysis and Bibliometrics analysis;Frontiers in Medicine;2023-05-05